Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
This study will examine the synaptotrophic effects of psilocybin among medically healthy, detoxified OUD subjects. Eligible OUD participants will undergo pre- and post- psilocybin administration PET scans with the [11C]-UCB-J radiotracer while inpatient.
- Status
- recruiting
- Phase
- Phase 1
- Institution
- Yale University
- Principal investigator
- Gustavo Angarita, MD, MHS
- Start date
- 2025-05-28
- End date
- 2027-01-01
- Registry ID
- NCT06160284
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.